These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38243939)

  • 1. Transdermal Drug Delivery System of Linagliptin Sustained-release Microparticle Gels:
    Liu J; Guo S; Hong S; Piao J; Piao M
    Curr Drug Deliv; 2024; 21(11):1537-1547. PubMed ID: 38243939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transdermal delivery system for glipizide.
    Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
    Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
    Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
    Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and Evaluation of Organogels Containing Hyaluronan Microparticles for Topical Delivery of Caffeine.
    Simsolo EE; Eroğlu İ; Tanrıverdi ST; Özer Ö
    AAPS PharmSciTech; 2018 Apr; 19(3):1367-1376. PubMed ID: 29380282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
    Akram M; Naqvi SB; Khan A
    Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia.
    Mylonaki I; Strano F; Deglise S; Allémann E; Alonso F; Corpataux JM; Dubuis C; Haefliger JA; Jordan O; Saucy F; Delie F
    J Control Release; 2016 Jun; 232():93-102. PubMed ID: 27091698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanostructured Lipid Carrier-Mediated Transdermal Delivery System of Glibenclamide for Gestational Diabetes: Pharmacokinetic and Pharmacodynamic Evaluation.
    Ashwini M; Sudheer P; Sogali BS
    Curr Drug Deliv; 2024; 21(10):1386-1407. PubMed ID: 38213159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin-loaded Invasomes Gel for Transdermal Delivery: Development, Optimization, in-vitro, and Preclinical Evaluation.
    Zafar A; Yasir M; Singh L; Jafar M; Warsi MH; Panda DS
    J Oleo Sci; 2024; 73(9):1221-1240. PubMed ID: 39218639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats.
    Zakaria EM; El-Gamal SF; Mahmoud SM; El-Nahas HM; El-Bassossy HM
    Pharm Dev Technol; 2024 Oct; 29(8):874-885. PubMed ID: 39311002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of β-cyclodextrin-based sustained release microparticles for oral insulin delivery.
    D'Souza B; Bhowmik T; Uddin MN; Oettinger C; D'Souza M
    Drug Dev Ind Pharm; 2015; 41(8):1288-93. PubMed ID: 25156483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4.
    Fu X; Shi Y; Wang H; Zhao X; Sun Q; Huang Y; Qi T; Lin G
    Int J Nanomedicine; 2019; 14():9275-9284. PubMed ID: 31819429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
    Sharma A; Singh AP; Harikumar SL
    Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm.
    Singh D; Singh AP; Singh D; Kesavan AK; Arora S; Tiwary AK; Bedi N
    Daru; 2020 Jun; 28(1):191-208. PubMed ID: 32034683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo sustained release of exenatide from vesicular phospholipid gels for type II diabetes.
    Zhang Y; Zhong Y; Hu M; Xiang N; Fu Y; Gong T; Zhang Z
    Drug Dev Ind Pharm; 2016; 42(7):1042-9. PubMed ID: 26558908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes.
    Prasad PS; Imam SS; Aqil M; Sultana Y; Ali A
    Drug Deliv; 2016; 23(3):1057-66. PubMed ID: 25033041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmucosal delivery of linagliptin for the treatment of type- 2 diabetes mellitus by ultra-thin nanofibers.
    Modgill V; Garg T; Goyal AK; Rath G
    Curr Drug Deliv; 2015; 12(3):323-32. PubMed ID: 25410375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-Step Sustained-Release PLGA/Hyaluronic Acid Gel Formulation for Intra-articular Administration.
    Noda T; Okuda T; Mizuno R; Ozeki T; Okamoto H
    Biol Pharm Bull; 2018; 41(6):937-943. PubMed ID: 29863082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devices.
    Li J; Chu MK; Lu B; Mirzaie S; Chen K; Gordijo CR; Plettenburg O; Giacca A; Wu XY
    Drug Deliv Transl Res; 2017 Aug; 7(4):529-543. PubMed ID: 28429276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical design and optimization of nano-transfersomes based chitosan gel for transdermal delivery of cefepime.
    Mirza R; Shah KU; Khan AU; Fawad M; Rehman AU; Ahmed N; Nawaz A; Shah SU; Alasmari AF; Alharbi M; Alasmari F; Hafeez Z; Haq SU
    Drug Dev Ind Pharm; 2024 Jun; 50(6):511-523. PubMed ID: 38718267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.